<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32276665</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1172</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>10</Day></PubDate></JournalIssue><Title>Orphanet journal of rare diseases</Title><ISOAbbreviation>Orphanet J Rare Dis</ISOAbbreviation></Journal><ArticleTitle>The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.</ArticleTitle><Pagination><StartPage>90</StartPage><MedlinePgn>90</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">90</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13023-020-01366-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">Kennedy's disease (KD), also known as spinal and bulbar muscular atrophy (SBMA), is a rare, adult-onset, X-linked recessive neuromuscular disease caused by CAG expansions in exon 1 of the androgen receptor gene (AR). The objective of the French national diagnostic and management protocol is to provide evidence-based best practice recommendations and outline an optimised care pathway for patients with KD, based on a systematic literature review and consensus multidisciplinary observations.</AbstractText><AbstractText Label="RESULTS">The initial evaluation, confirmation of the diagnosis, and management should ideally take place in a tertiary referral centre for motor neuron diseases, and involve an experienced multidisciplinary team of neurologists, endocrinologists, cardiologists and allied healthcare professionals. The diagnosis should be suspected in an adult male presenting with slowly progressive lower motor neuron symptoms, typically affecting the lower limbs at onset. Bulbar involvement (dysarthria and dysphagia) is often a later manifestation of the disease. Gynecomastia is not a constant feature, but is suggestive of a suspected diagnosis, which is further supported by electromyography showing diffuse motor neuron involvement often with asymptomatic sensory changes. A suspected diagnosis is confirmed by genetic testing. The multidisciplinary assessment should ascertain extra-neurological involvement such as cardiac repolarisation abnormalities (Brugada syndrome), signs of androgen resistance, genitourinary abnormalities, endocrine and metabolic changes (glucose intolerance, hyperlipidemia). In the absence of effective disease modifying therapies, the mainstay of management is symptomatic support using rehabilitation strategies (physiotherapy and speech therapy). Nutritional evaluation by an expert dietician is essential, and enteral nutrition (gastrostomy) may be required. Respiratory management centres on the detection and treatment of bronchial obstructions, as well as screening for aspiration pneumonia (chest physiotherapy, drainage, positioning, breath stacking, mechanical insufflation-exsufflation, cough assist machnie, antibiotics). Non-invasive mechanical ventilation is seldom needed. Symptomatic pharmaceutical therapy includes pain management, endocrine and metabolic interventions. There is no evidence for androgen substitution therapy.</AbstractText><AbstractText Label="CONCLUSION">The French national Kennedy's disease protocol provides management recommendations for patients with KD. In a low-incidence condition, sharing and integrating regional expertise, multidisciplinary experience and defining consensus best-practice recommendations is particularly important. Well-coordinated collaborative efforts will ultimately pave the way to the development of evidence-based international guidelines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pradat</LastName><ForeName>Pierre-Fran&#xe7;ois</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Universit&#xe9;, site Piti&#xe9;-Salp&#xea;tri&#xe8;re, D&#xe9;partement de Neurologie, Centre de Reference pour la SLA et les Maladies du Motoneurone, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, 47 Boulevard de l'H&#xf4;pital - F-75634, 13, Paris Cedex, France. pierre-francois.pradat@psl.aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernard</LastName><ForeName>Emilien</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Service d'&#xe9;lectromyographie et pathologies neuromusculaire, Centre de Reference pour la SLA et les Maladies du Motoneurone, CHU Lyon H&#xf4;pital Neurologique P. Wertheimer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcia</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, Centre de Reference pour la SLA et les Maladies du Motoneurone, CHU Tours, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, Centre de Reference pour la SLA et les Maladies du Motoneurone, CHU Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jublanc</LastName><ForeName>Christel</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Universit&#xe9;, site Piti&#xe9;-Salp&#xea;tri&#xe8;re D&#xe9;partement d'endocrinologie, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Querin</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Universit&#xe9;, site Piti&#xe9;-Salp&#xea;tri&#xe8;re, D&#xe9;partement de Neurologie, Centre de Reference pour la SLA et les Maladies du Motoneurone, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, 47 Boulevard de l'H&#xf4;pital - F-75634, 13, Paris Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mor&#xe9;lot Panzini</LastName><ForeName>Capucine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Universit&#xe9;, site Piti&#xe9;-Salp&#xea;tri&#xe8;re, Service de Pneumologie, M&#xe9;decine Intensive et R&#xe9;animation (D&#xe9;partement R3S), F-75013, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, INSERM, UMRS1158 Neurophysiologie Respiratoire Exp&#xe9;rimentale et Clinique, F-75005, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salachas</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Universit&#xe9;, site Piti&#xe9;-Salp&#xea;tri&#xe8;re, D&#xe9;partement de Neurologie, Centre de Reference pour la SLA et les Maladies du Motoneurone, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vial</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service d'&#xe9;lectromyographie et pathologies neuromusculaire, Centre de Reference pour la SLA et les Maladies du Motoneurone, CHU Lyon H&#xf4;pital Neurologique P. Wertheimer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahbi</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>AP-HP, CHU Cochin, Service de cardiologie, Centre de r&#xe9;f&#xe9;rence des maladies neuromusculaires Nord/Est/Ile de France, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bede</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Universit&#xe9;, site Piti&#xe9;-Salp&#xea;tri&#xe8;re, D&#xe9;partement de Neurologie, Centre de Reference pour la SLA et les Maladies du Motoneurone, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, 47 Boulevard de l'H&#xf4;pital - F-75634, 13, Paris Cedex, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desnuelle</LastName><ForeName>Claude</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>P&#xf4;le Neurosciences - Service de Neurologie, Centre de R&#xe9;f&#xe9;rence SLA et les maladies du neurone moteur, H&#xf4;pital Pasteur2, CHU de Nice Universit&#xe9; C&#xf4;te d'Azur, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>French Kennedy&#x2019;s Disease Writing Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Orphanet J Rare Dis</MedlineTA><NlmUniqueID>101266602</NlmUniqueID><ISSNLinking>1750-1172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Androgen insensitivity</Keyword><Keyword MajorTopicYN="N">Androgen receptor</Keyword><Keyword MajorTopicYN="N">Guidelines</Keyword><Keyword MajorTopicYN="N">Kennedy disease</Keyword><Keyword MajorTopicYN="N">Polyglutamine</Keyword><Keyword MajorTopicYN="N">Spinal and bulbar muscular atrophy</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Le Forestier</LastName><ForeName>Nadine</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Echaniz-Laguna</LastName><ForeName>Andoni</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Querin</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sorar&#xf9;</LastName><ForeName>Gianni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perez</LastName><ForeName>Thierry</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramos</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goizet</LastName><ForeName>Cyril</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desport</LastName><ForeName>Jean Claude</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pugeat</LastName><ForeName>Michel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pichon</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maniez</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robillard</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coupe</LastName><ForeName>Christophe</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laurier Betram</LastName><ForeName>Laurence</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roy Bellina</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xe9;v&#xea;que</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Penot</LastName><ForeName>J&#xe9;r&#xf4;me</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goutines Caramel</LastName><ForeName>Val&#xe9;rie</ForeName><Initials>V</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32276665</ArticleId><ArticleId IdType="pmc">PMC7149864</ArticleId><ArticleId IdType="doi">10.1186/s13023-020-01366-z</ArticleId><ArticleId IdType="pii">10.1186/s13023-020-01366-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Querin G, Sorar&#xf9; G, Pradat PF. Kennedy disease (X-linked recessive bulbospinal neuronopathy): a comprehensive review from pathophysiology to therapy. Rev Neurol. 2017;173:326&#x2013;337. doi: 10.1016/j.neurol.2017.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2017.03.019</ArticleId><ArticleId IdType="pubmed">28473226</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Bede P, Marchand-Pauvert V, Pradat PF. Biomarkers of spinal and bulbar muscle atrophy (SBMA): a comprehensive review. Front Neurol. 2018;9:844. doi: 10.3389/fneur.2018.00844.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00844</ArticleId><ArticleId IdType="pmc">PMC6191472</ArticleId><ArticleId IdType="pubmed">30364135</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;79. doi: 10.1038/352077a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007;30:575&#x2013;621. doi: 10.1146/annurev.neuro.29.051605.113042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.29.051605.113042</ArticleId><ArticleId IdType="pubmed">17417937</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, Abe K, Aoki M, Yasuo K, Itoyama Y, Shoji M, Ikeda Y, Iizuka T, Ikeda M, Shizuka M, Mizushima K, Hirai S. Mitotic and meiotic stability of the CAG repeat in the X-linked spinal and bulbar muscular atrophy gene. Clin Genet. 1996;50:133&#x2013;137. doi: 10.1111/j.1399-0004.1996.tb02367.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.1996.tb02367.x</ArticleId><ArticleId IdType="pubmed">8946111</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Miwa S, Kobayashi Y, Merry DE, Yamamoto M, Tanaka F, Doyu M, Hashizume Y, Fischbeck KH, Sobue G. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol. 1998;44:249&#x2013;254. doi: 10.1002/ana.410440216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440216</ArticleId><ArticleId IdType="pubmed">9708548</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Fischbeck KH. Spinal and bulbar muscular atrophy. Neurol Clin. 2015;33:847&#x2013;854. doi: 10.1016/j.ncl.2015.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.002</ArticleId><ArticleId IdType="pmc">PMC4628725</ArticleId><ArticleId IdType="pubmed">26515625</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie HL, Cho MS, Holder L, Liu Y, Tsvetkov AS, Finkbeiner S, Merry DE. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet. 2009;18:1937&#x2013;1950. doi: 10.1093/hmg/ddp115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp115</ArticleId><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomik B, Partyka D, Sulek A, Kurek-Gryz EA, Banach M, Ostrowska M, Zaremba J, Figlewicz DA, Szczudlik A. A phenotypic-genetic study of a group of polish patients with spinal and bulbar muscular atrophy. Amyotrophic Lateral Sclerosis. 2006;7:72&#x2013;79. doi: 10.1080/17482960600664839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600664839</ArticleId><ArticleId IdType="pubmed">16753970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennuto M, Greensmith L, Pradat PF, Sorar&#xf9; G. 210th ENMC international workshop: research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 march, 2015, Naarden, the Netherlands. Neuromuscul Disord. 2015;25:802&#x2013;812. doi: 10.1016/j.nmd.2015.06.462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2015.06.462</ArticleId><ArticleId IdType="pubmed">26206601</ArticleId></ArticleIdList></Reference><Reference><Citation>Greensmith L, Pradat PF, Sorar&#xf9; G, Pennuto M. 241st ENMC international workshop: towards a European unifying lab for Kennedy's disease. 15-17th February, 2019 Hoofddorp, the Netherlands. Neuromuscul Disord. 2019;29:716&#x2013;724. doi: 10.1016/j.nmd.2019.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2019.07.008</ArticleId><ArticleId IdType="pubmed">31488386</ArticleId></ArticleIdList></Reference><Reference><Citation>Pareyson D, Fratta P, Pradat PF, Sorar&#xf9; G, Finsterer J, Vissing J, Jokela ME, Udd B, Ludolph AC, Sagnelli A, Weydt P. Towards a European registry and biorepository for patients with spinal and bulbar muscular atrophy. J Mol Neurosci. 2016;58:394&#x2013;400. doi: 10.1007/s12031-015-0704-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-015-0704-5</ArticleId><ArticleId IdType="pubmed">26744358</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Sagnelli A, Rosenbohm A, Fratta P, Pradat PF, Ludolph AC, Pareyson D. Clinical trials in spinal and bulbar muscular atrophy-past, present, and future. J Mol Neurosci. 2016;58:379&#x2013;387. doi: 10.1007/s12031-015-0682-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-015-0682-7</ArticleId><ArticleId IdType="pubmed">26572537</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, Jeffries NO, Shrader JA, Lehky TJ, Li L, Ryder JE, Levy EW, Solomon BI, Harris-Love MO, La Pean A, Schindler AB, Chen C, Di Prospero NA, Fischbeck KH. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol. 2011;10:140&#x2013;147. doi: 10.1016/S1474-4422(10)70321-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70321-5</ArticleId><ArticleId IdType="pmc">PMC3056353</ArticleId><ArticleId IdType="pubmed">21216197</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I, Sasaki H, Aoki M, Morita M, Nakano I, Kanai K, Ito S, Ishikawa K, Mizusawa H, Yamamoto T, Tsuji S, Hasegawa K, Shimohata T, Nishizawa M, Miyajima H, Kanda F, Watanabe Y, Nakashima K, Tsujino A, Yamashita T, Uchino M, Fujimoto Y, Tanaka F, Sobue G. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9:875&#x2013;884. doi: 10.1016/S1474-4422(10)70182-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70182-4</ArticleId><ArticleId IdType="pubmed">20691641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Yu Z, Murray S, Peralta R, Low A, Guo S, Yu XX, Cortes CJ, Bennett CF, Monia BP, La Spada AR, Hung G. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 2014;7:774&#x2013;784. doi: 10.1016/j.celrep.2014.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanco MJ, Parodi S, Piol D, Stack C, Chivet M, Contestabile A, Miranda HC, Lievens PM, Espinoza S, Jochum T, Rocchi A, Grunseich C, Gainetdinov RR, Cato AC, Lieberman AP, La Spada AR, Sambataro F, Fischbeck KH, Gozes I, Pennuto M Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. SciTranslational Med 2016 8:370ra181.</Citation><ArticleIdList><ArticleId IdType="pubmed">28003546</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, Burnett BG, Young JE, Brenne PL, La Spada AR, Fischbeck KH, Howell BW, Pennuto M. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum Mol Genet. 2007;16:1593&#x2013;1603. doi: 10.1093/hmg/ddm109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm109</ArticleId><ArticleId IdType="pubmed">17470458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund A, Udd B, Juvonen V, Andersen PM, Cederquist K, Davis M, Gellera C, Kolmel C, Ronnevi LO, Sperfeld AD, Sorensen SA, Tranebjaerg L, Van Maldergem L, Watanabe M, Weber M, Yeung L, Savontaus ML. Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world. Eur J Human Genetics. 2001;9:431&#x2013;436. doi: 10.1038/sj.ejhg.5200656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejhg.5200656</ArticleId><ArticleId IdType="pubmed">11436124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolin C, Querin G, Martinelli I, Pennuto M, Pegoraro E, Sorar&#xf9; G. Insights into the genetic epidemiology of spinal and bulbar muscular atrophy: prevalence estimation and multiple founder haplotypes in the Veneto Italian region. Eur J Neurol. 2019;26:519&#x2013;524. doi: 10.1111/ene.13850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13850</ArticleId><ArticleId IdType="pubmed">30351503</ArticleId></ArticleIdList></Reference><Reference><Citation>Parboosingh JS, Figlewicz DA, Krizus A, Meininger V, Azad NA, Newman DS, Rouleau GA. Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology. 1997;49:568&#x2013;572. doi: 10.1212/WNL.49.2.568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.49.2.568</ArticleId><ArticleId IdType="pubmed">9270598</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejager S, Bry-Gauillard H, Bruckert E, Eymard B, Salachas F, LeGuern E, Tardieu S, Chadarevian R, Giral P, Turpin G. A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab. 2002;87:3893&#x2013;3901.</Citation><ArticleIdList><ArticleId IdType="pubmed">12161529</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperfeld AD, Hanemann CO, Ludolph AC, Kassubek J. Laryngospasm: an underdiagnosed symptom of X-linked spinobulbar muscular atrophy. Neurology. 2005;64:753&#x2013;754. doi: 10.1212/01.WNL.0000151978.74467.E7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000151978.74467.E7</ArticleId><ArticleId IdType="pubmed">15728312</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, Tanaka F, Tamakoshi A, Sobue G. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain. 2006;129:1446&#x2013;1455. doi: 10.1093/brain/awl096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl096</ArticleId><ArticleId IdType="pubmed">16621916</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahin N, Klein C, Mandrekar J, Sorenson E. Natural history of spinal-bulbar muscular atrophy. Neurology. 2008;70:1967&#x2013;1971. doi: 10.1212/01.wnl.0000312510.49768.eb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000312510.49768.eb</ArticleId><ArticleId IdType="pubmed">18490617</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes LE, Freeman BK, Auh S, Kokkinis AD, La Pean A, Chen C, Lehky TJ, Shrader JA, Levy EW, Harris-Love M, Di Prospero NA, Fischbeck KH. Clinical features of spinal and bulbar muscular atrophy. Brain. 2009;132:3242&#x2013;3251. doi: 10.1093/brain/awp258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp258</ArticleId><ArticleId IdType="pmc">PMC2792370</ArticleId><ArticleId IdType="pubmed">19846582</ArticleId></ArticleIdList></Reference><Reference><Citation>Soukup GR, Sperfeld AD, Uttner I, Karitzky J, Ludolph AC, Kassubek J, Schreiber H. Frontotemporal cognitive function in X-linked spinal and bulbar muscular atrophy (SBMA): a controlled neuropsychological study of 20 patients. J Neurol. 2009;256:1869&#x2013;1875. doi: 10.1007/s00415-009-5212-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5212-5</ArticleId><ArticleId IdType="pubmed">19572162</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Mano T, Atsuta N, Oe H, Watanabe H, Tanaka F, Sobue G. Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain. 2012;135:2838&#x2013;2848. doi: 10.1093/brain/aws170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws170</ArticleId><ArticleId IdType="pubmed">22773541</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki A, Katsuno M, Suzuki K, Banno H, Suga N, Hashizume A, Mano T, Hijikata Y, Nakatsuji H, Watanabe H, Yamamoto M, Makiyama T, Ohno S, Fukuyama M, Morimoto S, Horie M, Sobue G. Brugada syndrome in spinal and bulbar muscular atrophy. Neurology. 2014;82:1813&#x2013;1821. doi: 10.1212/WNL.0000000000000434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000434</ArticleId><ArticleId IdType="pubmed">24759840</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Bertolin C, Da Re E, Volpe M, Zara G, Pegoraro E, Caretta N, Foresta C, Silvano M, Corrado D, Iafrate M, Angelini L, Sartori L, Pennuto M, Gaiani A, Bello L, Semplicini C, Pareyson D, Silani V, Ermani M, Ferlin A, Sorar&#xf9; G. Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients. J Neurol Neurosurg Psychiatry. 2016;87:810&#x2013;816. doi: 10.1136/jnnp-2015-311305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311305</ArticleId><ArticleId IdType="pmc">PMC4975824</ArticleId><ArticleId IdType="pubmed">26503015</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolin C, Querin G, Da Re E, Sagnelli A, Bello L, Cao M, Muscas M, Pennuto M, Ermani M, Pegoraro E, Mariotti C, Gellera C, Hanna MG, Pareyson D, Fratta P, Sorar&#xf9; G. No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype. Eur J Neurol. 2016;23:1134&#x2013;1136. doi: 10.1111/ene.13001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13001</ArticleId><ArticleId IdType="pubmed">27141859</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordenvall AS, Paucar M, Almqvist C, Nordenstrom A, Frisen L, Nordenskjold A. Hypospadias as a novel feature in spinal bulbar muscle atrophy. J Neurol. 2016;263:703&#x2013;706. doi: 10.1007/s00415-016-8038-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8038-y</ArticleId><ArticleId IdType="pubmed">26872663</ArticleId></ArticleIdList></Reference><Reference><Citation>Francini-Pesenti F, Querin G, Martini C, Mareso S, Sacerdoti D. Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of italian patients with spinal-bulbar muscular atrophy. Acta Myologica. 2018;37:204&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6390113</ArticleId><ArticleId IdType="pubmed">30838350</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A, Hirsch S, Volk AE, Grehl T, Grosskreutz J, Hanisch F, Herrmann A, Kollewe K, Kress W, Meyer T, Petri S, Prudlo J, Wessig C, Muller HP, Dreyhaupt J, Weishaupt J, Kubisch C, Kassubek J, Weydt P, Ludolph AC. The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy. J Neurol. 2018;265:1026&#x2013;1036. doi: 10.1007/s00415-018-8790-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8790-2</ArticleId><ArticleId IdType="pubmed">29464380</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcato S, Kleinbub JR, Querin G, Pick E, Martinelli I, Bertolin C, Cipolletta S, Pegoraro E, Sorar&#xf9; G, Palmieri A. Unimpaired neuropsychological performance and enhanced memory recall in patients with Sbma: a large sample comparative study. Sci Rep. 2018;8:13627. doi: 10.1038/s41598-018-32062-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32062-5</ArticleId><ArticleId IdType="pmc">PMC6134140</ArticleId><ArticleId IdType="pubmed">30206283</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli EG, Agosta F, Ferraro PM, Querin G, Riva N, Bertolin C, Martinelli I, Lunetta C, Fontana A, Sorar&#xf9; G, Filippi M. Brain MRI shows white matter sparing in Kennedy's disease and slow-progressing lower motor neuron disease. Hum Brain Mapp. 2019;40:3102&#x2013;3112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865482</ArticleId><ArticleId IdType="pubmed">30924230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata T, Muroya K, Ishii T, Suzuki Y, Nakada T, Sasagawa I. Undermasculinized genitalia in a boy with an abnormally expanded CAG repeat length in the androgen receptor gene. Clin Endocrinol. 2001;54:835&#x2013;838. doi: 10.1046/j.1365-2265.2001.01205.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2265.2001.01205.x</ArticleId><ArticleId IdType="pubmed">11422120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmi S, Inoue K, Kutoku Y, Rikimaru M, Murakami T, Sunada Y (2009) [two brothers with very late onset of muscle weakness in X-linked recessive spinal and bulbar muscular atrophy]. Rinsho shinkeigaku = clinical neurology 49:22-26.</Citation><ArticleIdList><ArticleId IdType="pubmed">19227892</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Sorar&#xf9; G. Onset manifestations of spinal and bulbar muscular atrophy (Kennedy's disease) J Mol Neurosci. 2016;58:321&#x2013;329. doi: 10.1007/s12031-015-0663-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-015-0663-x</ArticleId><ArticleId IdType="pubmed">26482145</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A, Rousso E, Anheim M, Cossee M, Tranchant C. A family with early-onset and rapidly progressive X-linked spinal and bulbar muscular atrophy. Neurology. 2005;64:1458&#x2013;1460. doi: 10.1212/01.WNL.0000158617.41819.F3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000158617.41819.F3</ArticleId><ArticleId IdType="pubmed">15851746</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Doherty CP, Elamin M, Bede P (2016) Neurodegenerative disorders: a clinical guide. Springer international publishing, springer Cham Heidelberg New York Dordrecht London&#xa9; springer international publishing Switzerland 2016.</Citation></Reference><Reference><Citation>Suzuki K, Katsuno M, Banno H, Takeuchi Y, Atsuta N, Ito M, Watanabe H, Yamashita F, Hori N, Nakamura T, Hirayama M, Tanaka F, Sobue G. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain. 2008;131:229&#x2013;239. doi: 10.1093/brain/awm289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm289</ArticleId><ArticleId IdType="pubmed">18056738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Lim YM, Lee EJ, Oh YJ, Kim KK. Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy. Muscle Nerve. 2018;57:683&#x2013;686. doi: 10.1002/mus.25977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25977</ArticleId><ArticleId IdType="pubmed">28972672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, Chen S, Qiao K, Wang N, Wu ZY. Genotype-phenotype correlation in Chinese patients with spinal and bulbar muscular atrophy. PLoS One. 2015;10:e0122279. doi: 10.1371/journal.pone.0122279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0122279</ArticleId><ArticleId IdType="pmc">PMC4374859</ArticleId><ArticleId IdType="pubmed">25811990</ArticleId></ArticleIdList></Reference><Reference><Citation>McManamny P, Chy HS, Finkelstein DI, Craythorn RG, Crack PJ, Kola I, Cheema SS, Horne MK, Wreford NG, O'Bryan MK, De Kretser DM, Morrison JR. A mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet. 2002;11:2103&#x2013;2111. doi: 10.1093/hmg/11.18.2103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.18.2103</ArticleId><ArticleId IdType="pubmed">12189162</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, Yu Z, Lieberman AP, Breedlove SM, Jordan CL. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A. 2007;104:18259&#x2013;18264. doi: 10.1073/pnas.0705501104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705501104</ArticleId><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, Nirmalananthan N, Masset L, Skorupinska I, Collins T, Cortese A, Pemble S, Malaspina A, Fisher EM, Greensmith L, Hanna MG. Correlation of clinical and molecular features in spinal bulbar muscular atrophy. Neurology. 2014;82:2077&#x2013;2084. doi: 10.1212/WNL.0000000000000507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000507</ArticleId><ArticleId IdType="pmc">PMC4075620</ArticleId><ArticleId IdType="pubmed">24814851</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperfeld AD, Karitzky J, Brummer D, Schreiber H, Haussler J, Ludolph AC, Hanemann CO. X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol. 2002;59:1921&#x2013;1926. doi: 10.1001/archneur.59.12.1921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.59.12.1921</ArticleId><ArticleId IdType="pubmed">12470181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Shin JH, Park KP, Kim IJ, Kim CM, Lim JG, Choi YC, Kim DS. Phenotypic variability in Kennedy's disease: implication of the early diagnostic features. Acta Neurol Scand. 2005;112:57&#x2013;63. doi: 10.1111/j.1600-0404.2005.00428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2005.00428.x</ArticleId><ArticleId IdType="pubmed">15932358</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A, Sugeno N, Tateyama M, Nishiyama S, Kato M, Aoki M. Postural leg tremor in X-linked spinal and bulbar muscular atrophy. J Clin Neurosci. 2014;21:799&#x2013;802. doi: 10.1016/j.jocn.2013.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2013.07.026</ArticleId><ArticleId IdType="pubmed">24256885</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias FA, Munhoz RP, Raskin S, Werneck LC, Teive HA. Tremor in X-linked recessive spinal and bulbar muscular atrophy (Kennedy's disease) Clinics (Sao Paulo, Brazil) 2011;66:955&#x2013;957. doi: 10.1590/S1807-59322011000600006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1807-59322011000600006</ArticleId><ArticleId IdType="pmc">PMC3129962</ArticleId><ArticleId IdType="pubmed">21808858</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanajima R, Terao Y, Nakatani-Enomoto S, Hamada M, Yugeta A, Matsumoto H, Yamamoto T, Tsuji S, Ugawa Y. Postural tremor in X-linked spinal and bulbar muscular atrophy. Mov Disord. 2009;24:2063&#x2013;2069. doi: 10.1002/mds.22566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22566</ArticleId><ArticleId IdType="pubmed">19746452</ArticleId></ArticleIdList></Reference><Reference><Citation>Boz C, Sahin N, Kalay E, Velioglu S, Ozmenoglu M. X-linked spinal and bulbar muscular atrophy without proximal atrophy. Clin Neurol Neurosurg. 2002;105:14&#x2013;17. doi: 10.1016/S0303-8467(02)00055-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0303-8467(02)00055-0</ArticleId><ArticleId IdType="pubmed">12445917</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariotti C, Castellotti B, Pareyson D, Testa D, Eoli M, Antozzi C, Silani V, Marconi R, Tezzon F, Siciliano G, Marchini C, Gellera C, Donato SD. Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord. 2000;10:391&#x2013;397. doi: 10.1016/S0960-8966(99)00132-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-8966(99)00132-7</ArticleId><ArticleId IdType="pubmed">10899444</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Sobue G, Doyu M, Mukai E, Hashizume Y, Mitsuma T. Primary sensory neurons in X-linked recessive bulbospinal neuropathy: histopathology and androgen receptor gene expression. Muscle Nerve. 1995;18:301&#x2013;308. doi: 10.1002/mus.880180306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880180306</ArticleId><ArticleId IdType="pubmed">7870107</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini G, Gragnani F, Romaniello A, Pennisi EM, Morino S, Ceschin V, Santoro L, Cruccu G. Sensory involvement in spinal-bulbar muscular atrophy (Kennedy's disease) Muscle Nerve. 2000;23:252&#x2013;258. doi: 10.1002/(SICI)1097-4598(200002)23:2&lt;252::AID-MUS17&gt;3.0.CO;2-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(200002)23:2&lt;252::AID-MUS17&gt;3.0.CO;2-P</ArticleId><ArticleId IdType="pubmed">10639619</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada M, Inaba A, Shiojiri T. X-linked spinal and bulbar muscular atrophy with myasthenic symptoms. J Neurol Sci. 1997;146:183&#x2013;185. doi: 10.1016/S0022-510X(96)00303-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(96)00303-6</ArticleId><ArticleId IdType="pubmed">9077516</ArticleId></ArticleIdList></Reference><Reference><Citation>Praline J, Guennoc AM, Malinge MC, de Toffol B, Corcia P. Pure bulbar motor neuron involvement linked to an abnormal CAG repeat expansion in the androgen receptor gene. Amyotrophic Lateral Sclerosis. 2008;9:40&#x2013;42. doi: 10.1080/17482960701553915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701553915</ArticleId><ArticleId IdType="pubmed">17852020</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenberghe N, Bouhour F, Petiot P, Gonnaud PM, Latour P, Broussolle E, Vial C. Multiple phenotypic manifestations of X-linked spinobulbar muscular atrophy. Rev Neurol. 2009;165:31&#x2013;37. doi: 10.1016/j.neurol.2008.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2008.06.005</ArticleId><ArticleId IdType="pubmed">18667219</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganelli F, Iodice V, Provitera V, Pisciotta C, Nolano M, Perretti A, Santoro L. Small-fiber involvement in spinobulbar muscular atrophy (Kennedy's disease) Muscle Nerve. 2007;36:816&#x2013;820. doi: 10.1002/mus.20872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20872</ArticleId><ArticleId IdType="pubmed">17691102</ArticleId></ArticleIdList></Reference><Reference><Citation>Romigi A, Liguori C, Placidi F, Albanese M, Izzi F, Uasone E, Terracciano C, Marciani MG, Mercuri NB, Ludovisi R, Massa R. Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study. J Neurol. 2014;261:889&#x2013;893. doi: 10.1007/s00415-014-7293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7293-z</ArticleId><ArticleId IdType="pubmed">24590405</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurtell MJ, Pioro EP, Leigh RJ. Abnormal eye movements in Kennedy disease. Neurology. 2009;72:1528&#x2013;1530. doi: 10.1212/WNL.0b013e3181a2e936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a2e936</ArticleId><ArticleId IdType="pmc">PMC2677481</ArticleId><ArticleId IdType="pubmed">19398709</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ, Thagesen H, Tomkins J, Slade JY, Usher P, Jackson A, Curtis A, Bushby K, Ince PG. Kennedy's disease: unusual molecular pathologic and clinical features. Neurology. 1998;51:252&#x2013;255. doi: 10.1212/WNL.51.1.252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.51.1.252</ArticleId><ArticleId IdType="pubmed">9674812</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler H, Prudlo J, Kraft S, Supprian T. Dementia of frontal lobe type in Kennedy's disease. Amyotrophic Lateral Sclerosis Motor Neuron Disorders. 2005;6:250&#x2013;253. doi: 10.1080/14660820510036558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510036558</ArticleId><ArticleId IdType="pubmed">16319030</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirowska-Guzel D, Seniow J, Sulek A, Lesniak M, Czlonkowska A. Are cognitive and behavioural deficits a part of the clinical picture in Kennedy's disease? A case study. Neurocase. 2009;15:332&#x2013;337. doi: 10.1080/13554790902842003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13554790902842003</ArticleId><ArticleId IdType="pubmed">19343581</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi H, Katsuno M, Minamiyama M, Waza M, Sang C, Nakagomi Y, Kobayashi Y, Tanaka F, Doyu M, Inukai A, Yoshida M, Hashizume Y, Sobue G. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain. 2005;128:659&#x2013;670. doi: 10.1093/brain/awh381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh381</ArticleId><ArticleId IdType="pubmed">15659427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper E, Wegrzyn M, Marx I, Korp C, Kress W, Benecke R, Teipel SJ, Prudlo J. Minor cognitive disturbances in X-linked spinal and bulbar muscular atrophy, Kennedy's disease. Amyotrophic Lateral Sclerosis Frontotemporal Degeneration. 2014;15:15&#x2013;20. doi: 10.3109/21678421.2013.837927.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.837927</ArticleId><ArticleId IdType="pubmed">24200287</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Rosa E, Sorar&#xf9; G, Kleinbub JR, Calvo V, Vallesi A, Querin G, Marcato S, Grasso I, Palmieri A. Theory of mind, empathy and neuropsychological functioning in X-linked spinal and bulbar muscular atrophy: a controlled study of 20 patients. J Neurol. 2015;262:394&#x2013;401. doi: 10.1007/s00415-014-7567-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7567-5</ArticleId><ArticleId IdType="pubmed">25408365</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O'Sullivan M, Lonergan K, Kirby E, Quinlan E, Breen N, Vajda A, Heverin M, Pender N, Hardiman O. Identifying behavioural changes in ALS: validation of the Beaumont Behavioural inventory (BBI) Amyotrophic Lateral Sclerosis Frontotemporal Degeneration. 2017;18:68&#x2013;73. doi: 10.1080/21678421.2016.1248976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1248976</ArticleId><ArticleId IdType="pubmed">27894191</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T, Pinto-Grau M, Lonergan K, Bede P, O'Sullivan M, Heverin M, Vajda A, McLaughlin RL, Pender N, Hardiman O. A cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clinical Translational Neurol. 2017;4:305&#x2013;317. doi: 10.1002/acn3.407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.407</ArticleId><ArticleId IdType="pmc">PMC5420811</ArticleId><ArticleId IdType="pubmed">28491898</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamovic T, Nordenskjold A. The CAG repeat polymorphism in the androgen receptor gene modifies the risk for hypospadias in Caucasians. BMC Medical Genetics. 2012;13:109. doi: 10.1186/1471-2350-13-109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-13-109</ArticleId><ArticleId IdType="pmc">PMC3560208</ArticleId><ArticleId IdType="pubmed">23167717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim HN, Chen H, McBride S, Dunning AM, Nixon RM, Hughes IA, Hawkins JR. Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males. Hum Mol Genet. 2000;9:829&#x2013;834. doi: 10.1093/hmg/9.5.829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.5.829</ArticleId><ArticleId IdType="pubmed">10749991</ArticleId></ArticleIdList></Reference><Reference><Citation>SANTE AFDSSDPD (2001) Mise au point sur les risques musculaires des statines. https://ansm.sante.fr/var/ansm_site/storage/original/application/c6090fc66b0777de27e12faf285d4be4.pdf.</Citation></Reference><Reference><Citation>Rocchi C, Greco V, Urbani A, Di Giorgio A, Priori M, Massa R, Bernardi G, Marfia GA. Subclinical autonomic dysfunction in spinobulbar muscular atrophy (Kennedy disease) Muscle Nerve. 2011;44:737&#x2013;740. doi: 10.1002/mus.22159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22159</ArticleId><ArticleId IdType="pubmed">22006688</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Kats IR, Bott LC, Rinaldi C, Kokkinis A, Fox D, Chen KL, Schindler AB, Mankodi AK, Shrader JA, Schwartz DP, Lehky TJ, Liu CY, Fischbeck KH. Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat. Neuromuscul Disord. 2014;24:978&#x2013;981. doi: 10.1016/j.nmd.2014.06.441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2014.06.441</ArticleId><ArticleId IdType="pmc">PMC4252652</ArticleId><ArticleId IdType="pubmed">25047668</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Melacini P, D'Ascenzo C, Morandi L, Mazzini L, Silani V, Romito S, Mandrioli J, Raimondi M, Pegoraro E, Sorar&#xf9; G. No evidence of cardiomyopathy in spinal and bulbar muscular atrophy. Acta Neurol Scand. 2013;128:e30&#x2013;e32. doi: 10.1111/ane.12140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12140</ArticleId><ArticleId IdType="pubmed">23679084</ArticleId></ArticleIdList></Reference><Reference><Citation>Koritsiadis G, Stravodimos K, Mitropoulos D, Doumanis G, Fokitis I, Koritsiadis S, Constantinides C. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study. BJU Int. 2008;101:1542&#x2013;1546. doi: 10.1111/j.1464-410X.2008.07521.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-410X.2008.07521.x</ArticleId><ArticleId IdType="pubmed">18294304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hama T, Hirayama M, Hara T, Nakamura T, Atsuta N, Banno H, Suzuki K, Katsuno M, Tanaka F, Sobue G. Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials. Muscle Nerve. 2012;45:169&#x2013;174. doi: 10.1002/mus.22291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22291</ArticleId><ArticleId IdType="pubmed">22246870</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Park KD, Kim SM, Sunwoo IN (2013) Decremental responses to repetitive nerve stimulation in x-linked bulbospinal muscular atrophy. Journal of clinical neurology (Seoul, Korea) 9:32-35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3543907</ArticleId><ArticleId IdType="pubmed">23346158</ArticleId></ArticleIdList></Reference><Reference><Citation>Noto Y, Misawa S, Mori M, Kawaguchi N, Kanai K, Shibuya K, Isose S, Nasu S, Sekiguchi Y, Beppu M, Ohmori S, Nakagawa M, Kuwabara S. Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: evidence of activity-dependent conduction block. Clin Neurophysiol. 2013;124:1893&#x2013;1898. doi: 10.1016/j.clinph.2012.12.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2012.12.053</ArticleId><ArticleId IdType="pubmed">23643309</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J, Cui L, Liu M, Guan Y, Li X, Li D, Cui B, Shen D, Ding Q. Differences in F-wave characteristics between Spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Front Aging Neurosci. 2016;8:50. doi: 10.3389/fnagi.2016.00050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2016.00050</ArticleId><ArticleId IdType="pmc">PMC4783393</ArticleId><ArticleId IdType="pubmed">27014057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehky TJ, Chen CJ, di Prospero NA, Rhodes LE, Fischbeck K, Floeter MK. Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophy. Muscle Nerve. 2009;40:809&#x2013;814. doi: 10.1002/mus.21399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21399</ArticleId><ArticleId IdType="pmc">PMC2763967</ArticleId><ArticleId IdType="pubmed">19670325</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashihara M, Sonoo M, Yamamoto T, Nagashima Y, Uesugi H, Terao Y, Ugawa Y, Stalberg E, Tsuji S. Evaluation of spinal and bulbar muscular atrophy by the clustering index method. Muscle Nerve. 2011;44:539&#x2013;546. doi: 10.1002/mus.22119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22119</ArticleId><ArticleId IdType="pubmed">21826683</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorar&#xf9; G, D'Ascenzo C, Polo A, Palmieri A, Baggio L, Vergani L, Gellera C, Moretto G, Pegoraro E, Angelini C. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci. 2008;264:100&#x2013;105. doi: 10.1016/j.jns.2007.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.08.012</ArticleId><ArticleId IdType="pubmed">17854832</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokela M, Huovinen S, Raheem O, Lindfors M, Palmio J, Penttila S, Udd B. Distinct muscle biopsy findings in genetically defined adult-onset motor neuron disorders. PLoS One. 2016;11:e0151376. doi: 10.1371/journal.pone.0151376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151376</ArticleId><ArticleId IdType="pmc">PMC4801364</ArticleId><ArticleId IdType="pubmed">26999347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson EJ, Klein CJ. Elevated creatine kinase and transaminases in asymptomatic SBMA. Amyotrophic Lateral Sclerosis. 2007;8:62&#x2013;64. doi: 10.1080/17482960600765040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600765040</ArticleId><ArticleId IdType="pubmed">17364438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi V, Querin G, Ziff OJ, Zampedri L, Martinelli I, Heller C, Foiani M, Bertolin C, Lu CH, Malik B, Allen K, Rinaldi C, Zetterberg H, Heslegrave A, Greensmith L, Hanna M, Sorar&#xf9; G, Malaspina A, Fratta P. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. Neurology. 2019;92:e1205&#x2013;e1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511101</ArticleId><ArticleId IdType="pubmed">30787165</ArticleId></ArticleIdList></Reference><Reference><Citation>Hijikata Y, Hashizume A, Yamada S, Inagaki T, Ito D, Hirakawa A, Suzuki K, Atsuta N, Tsuboi T, Hattori M, Hori A, Banno H, Sobue G, Katsuno M. Biomarker-based analysis of preclinical progression in spinal and bulbar muscular atrophy. Neurology. 2018;90:e1501&#x2013;e1509. doi: 10.1212/WNL.0000000000005360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005360</ArticleId><ArticleId IdType="pubmed">29572281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Querin G, Pradat PF. The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools. Curr Opin Neurol. 2018;31:431&#x2013;438. doi: 10.1097/WCO.0000000000000569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000569</ArticleId><ArticleId IdType="pubmed">29750730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, Juengling FD, Sperfeld AD. Widespread white matter changes in Kennedy disease: a voxel based morphometry study. J Neurol Neurosurg Psychiatry. 2007;78:1209&#x2013;1212. doi: 10.1136/jnnp.2006.112532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.112532</ArticleId><ArticleId IdType="pmc">PMC2117581</ArticleId><ArticleId IdType="pubmed">17332050</ArticleId></ArticleIdList></Reference><Reference><Citation>Unrath A, Muller HP, Riecker A, Ludolph AC, Sperfeld AD, Kassubek J. Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum Brain Mapp. 2010;31:1727&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871219</ArticleId><ArticleId IdType="pubmed">20336652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebouteux MV, Franques J, Guillevin R, Delmont E, Lenglet T, Bede P, Desnuelle C, Pouget J, Pascal-Mousselard H, Pradat PF. Revisiting the spectrum of lower motor neuron diseases with snake eyes appearance on magnetic resonance imaging. Eur J Neurol. 2014;21:1233&#x2013;1241. doi: 10.1111/ene.12465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12465</ArticleId><ArticleId IdType="pubmed">24847978</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Bokde AL, Byrne S, Elamin M, Fagan AJ, Hardiman O. Spinal cord markers in ALS: diagnostic and biomarker considerations. Amyotrophic Lateral Sclerosis. 2012;13:407&#x2013;415. doi: 10.3109/17482968.2011.649760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.649760</ArticleId><ArticleId IdType="pubmed">22329869</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, El Mendili MM, Bede P, Delphine S, Lenglet T, Marchand-Pauvert V, Pradat PF (2018) Multimodal spinal cord MRI offers accurate diagnostic classification in ALS. Journal of neurology, neurosurgery, and psychiatry.</Citation><ArticleIdList><ArticleId IdType="pubmed">29353238</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O. Lessons of ALS imaging: pitfalls and future directions - a critical review. NeuroImage Clinical. 2014;4:436&#x2013;443. doi: 10.1016/j.nicl.2014.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2014.02.011</ArticleId><ArticleId IdType="pmc">PMC3950559</ArticleId><ArticleId IdType="pubmed">24624329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieper CC, Konrad C, Sommer J, Teismann I, Schiffbauer H. Structural changes of central white matter tracts in Kennedy's disease - a diffusion tensor imaging and voxel-based morphometry study. Acta Neurol Scand. 2013;127:323&#x2013;328. doi: 10.1111/ane.12018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12018</ArticleId><ArticleId IdType="pubmed">23216624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlqvist JR, Oestergaard ST, Poulsen NS, Thomsen C, Vissing J. Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments. Neurology. 2019;92:e548&#x2013;e559. doi: 10.1212/WNL.0000000000006887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006887</ArticleId><ArticleId IdType="pubmed">30610091</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlqvist JR, Fornander F, de Stricker BJ, Oestergaard ST, Poulsen NS, Vissing J. Disease progression and outcome measures in spinobulbar muscular atrophy. Ann Neurol. 2018;84:754&#x2013;765. doi: 10.1002/ana.25345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25345</ArticleId><ArticleId IdType="pubmed">30255951</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Elamin M, Byrne S, Hardiman O. Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3-4):235&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">24344910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Sachdev PS, Wen W, Anstey KJ. Sex differences in regional gray matter in healthy individuals aged 44-48 years: a voxel-based morphometric study. NeuroImage. 2007;36:691&#x2013;699. doi: 10.1016/j.neuroimage.2007.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2007.03.063</ArticleId><ArticleId IdType="pubmed">17499524</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzler K, Belke M, Wehrmann E, Krakow K, Lengler U, Jansen A, Hamer HM, Oertel WH, Rosenow F, Knake S. Men and women are different: diffusion tensor imaging reveals sexual dimorphism in the microstructure of the thalamus, corpus callosum and cingulum. NeuroImage. 2011;54:2557&#x2013;2562. doi: 10.1016/j.neuroimage.2010.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2010.11.029</ArticleId><ArticleId IdType="pubmed">21087671</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotrophic Lateral Sclerosis &amp; Frontotemporal Degeneration. 2018;19:232&#x2013;241. doi: 10.1080/21678421.2017.1407795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1407795</ArticleId><ArticleId IdType="pubmed">29214883</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Elamin M, Hardiman O, Bede P. Presymptomatic and longitudinal neuroimaging in neurodegeneration--from snapshots to motion picture: a systematic review. J Neurol Neurosurg Psychiatry. 2015;86:1089&#x2013;1096. doi: 10.1136/jnnp-2014-309888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309888</ArticleId><ArticleId IdType="pubmed">25632156</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Iyer PM, Schuster C, Elamin M, McLaughlin RL, Kenna K, Hardiman O. The selective anatomical vulnerability of ALS: 'disease-defining' and 'disease-defying' brain regions. Amyotrophic lateral Sclerosis Frontotemporal Degeneration. 2016;17:561&#x2013;570. doi: 10.3109/21678421.2016.1173702.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1173702</ArticleId><ArticleId IdType="pubmed">27087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F, Karavasilis E, Rentzos M, Kelekis N, Evdokimidis I, Bede P. Clinical and radiological markers of extra-motor deficits in amyotrophic lateral sclerosis. Front Neurol. 2018;9:1005. doi: 10.3389/fneur.2018.01005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01005</ArticleId><ArticleId IdType="pmc">PMC6262087</ArticleId><ArticleId IdType="pubmed">30524366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Omer T, Finegan E, Chipika RH, Iyer PM, Doherty MA, Vajda A, Pender N, McLaughlin RL, Hutchinson S, Hardiman O. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behavior. 2018;12:1696&#x2013;1707. doi: 10.1007/s11682-018-9837-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-018-9837-9</ArticleId><ArticleId IdType="pubmed">29423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, El Mendili MM, Lenglet T, Behin A, Stojkovic T, Salachas F, Devos D, Le Forestier N, Del Mar AM, Debs R, Lacomblez L, Meninger V, Bruneteau G, Cohen-Adad J, Lehericy S, Laforet P, Blancho S, Benali H, Catala M, Li M, Marchand-Pauvert V, Hogrel JY, Bede P, Pradat PF. The spinal and cerebral profile of adult spinal-muscular atrophy: a multimodal imaging study. NeuroImage Clinical. 2019;21:101618. doi: 10.1016/j.nicl.2018.101618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.101618</ArticleId><ArticleId IdType="pmc">PMC6413472</ArticleId><ArticleId IdType="pubmed">30522974</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidi M, de Marco G, Couillandre A, Feron M, Mseddi E, Termoz N, Querin G, Pradat PF, Bede P. Adaptive functional reorganization in amyotrophic lateral sclerosis: coexisting degenerative and compensatory changes. Eur J Neurol. 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31310452</ArticleId></ArticleIdList></Reference><Reference><Citation>Proudfoot M, Bede P, Turner MR. Imaging cerebral activity in amyotrophic lateral sclerosis. Front Neurol. 2018;9:1148. doi: 10.3389/fneur.2018.01148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01148</ArticleId><ArticleId IdType="pmc">PMC6332509</ArticleId><ArticleId IdType="pubmed">30671016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai TH, Liu RS, Yang BH, Wang PS, Lin KP, Lee YC, Soong BW. Cerebral involvement in spinal and bulbar muscular atrophy (Kennedy's disease): a pilot study of PET. J Neurol Sci. 2013;335:139&#x2013;144. doi: 10.1016/j.jns.2013.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2013.09.016</ArticleId><ArticleId IdType="pubmed">24120273</ArticleId></ArticleIdList></Reference><Reference><Citation>Klickovic U, Zampedri L, Sinclair CDJ, Wastling SJ, Trimmel K, Howard RS, Malaspina A, Sharma N, Sidle K, Emira A, Shah S, Yousry TA, Hanna MG, Greensmith L, Morrow JM, Thornton JS, Fratta P. Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity. Neurology. 2019;93:e895&#x2013;e907. doi: 10.1212/WNL.0000000000008009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008009</ArticleId><ArticleId IdType="pmc">PMC6745729</ArticleId><ArticleId IdType="pubmed">31391248</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology. 2002;59:770&#x2013;772. doi: 10.1212/WNL.59.5.770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.5.770</ArticleId><ArticleId IdType="pubmed">12221177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika RH, Finegan E, Li Hi Shing S, Hardiman O, Bede P. Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS. Front Neurol. 2019;10:229. doi: 10.3389/fneur.2019.00229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00229</ArticleId><ArticleId IdType="pmc">PMC6433752</ArticleId><ArticleId IdType="pubmed">30941088</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Hardiman O, Bede P. Survival prediction in amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol. 2017;17:73. doi: 10.1186/s12883-017-0854-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-017-0854-x</ArticleId><ArticleId IdType="pmc">PMC5393027</ArticleId><ArticleId IdType="pubmed">28412941</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V, Pradat PF, Querin G, Delbot F, Le Chat G, Pradat-Peyre JF, Bede P. Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions. Front Neurosci. 2019;13:135. doi: 10.3389/fnins.2019.00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00135</ArticleId><ArticleId IdType="pmc">PMC6403867</ArticleId><ArticleId IdType="pubmed">30872992</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Hardiman O, Bede P. Development of an automated MRI-based diagnostic protocol for amyotrophic lateral sclerosis using disease-specific pathognomonic features: a quantitative disease-state classification study. PLoS One. 2016;11:e0167331. doi: 10.1371/journal.pone.0167331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0167331</ArticleId><ArticleId IdType="pmc">PMC5132189</ArticleId><ArticleId IdType="pubmed">27907080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Iyer PM, Finegan E, Omer T, Hardiman O. Virtual brain biopsies in amyotrophic lateral sclerosis: diagnostic classification based on in vivo pathological patterns. NeuroImage Clin. 2017;15:653&#x2013;658. doi: 10.1016/j.nicl.2017.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.06.010</ArticleId><ArticleId IdType="pmc">PMC5479963</ArticleId><ArticleId IdType="pubmed">28664036</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Li Hi Shing S, Chipika RH, Doherty MA, Hengeveld JC, Vajda A, Donaghy C, Pender N, McLaughlin RL, Hardiman O, Bede P. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling. NeuroImage Clinical. 2019;24:102089. doi: 10.1016/j.nicl.2019.102089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102089</ArticleId><ArticleId IdType="pmc">PMC6978214</ArticleId><ArticleId IdType="pubmed">31795059</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Chipika RH, Finegan E, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, Hutchinson S, Donaghy C, McLaughlin RL, Hardiman O. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: a longitudinal neuroimaging study. NeuroImage Clinical. 2019;24:102054. doi: 10.1016/j.nicl.2019.102054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102054</ArticleId><ArticleId IdType="pmc">PMC6849418</ArticleId><ArticleId IdType="pubmed">31711033</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Querin G, Bede P, Pradat PF. Spinal cord imaging in amyotrophic lateral sclerosis: historical concepts-novel techniques. Front Neurol. 2019;10:350. doi: 10.3389/fneur.2019.00350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00350</ArticleId><ArticleId IdType="pmc">PMC6474186</ArticleId><ArticleId IdType="pubmed">31031688</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Bede P, El Mendili MM, Li M, Pelegrini-Issac M, Rinaldi D, Catala M, Saracino D, Salachas F, Camuzat A, Marchand-Pauvert V, Cohen-Adad J, Colliot O, Le Ber I, Pradat PF. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: a longitudinal neuroimaging study. Ann Neurol. 2019;86:158&#x2013;167. doi: 10.1002/ana.25520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25520</ArticleId><ArticleId IdType="pubmed">31177556</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Chipika RH, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, Donaghy C, McLaughlin RL, Pender N, Hardiman O, Bede P. The clinical and radiological profile of primary lateral sclerosis: a population-based study. J Neurol. 2019;266:2718&#x2013;2733. doi: 10.1007/s00415-019-09473-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09473-z</ArticleId><ArticleId IdType="pubmed">31325016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikezoe K, Yoshimura T, Taniwaki T, Matsuura E, Furuya H, Yamada T, Nagamatsu K, Kira J. Autosomal dominant familial spinal and bulbar muscular atrophy with gynecomastia. Neurology. 1999;53:2187&#x2013;2189. doi: 10.1212/WNL.53.9.2187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.53.9.2187</ArticleId><ArticleId IdType="pubmed">10599805</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Bokde AL, Byrne SC, Elamin M, Walsh RJ, Hardiman O. Waterskier's Hirayama syndrome. J Neurol. 2011;258:2078&#x2013;2079. doi: 10.1007/s00415-011-6046-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6046-5</ArticleId><ArticleId IdType="pubmed">21503827</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Lenglet T, Debs R, Stojkovic T, Behin A, Salachas F, Le Forestier N, Amador MDM, Lacomblez L, Meininger V, Bruneteau G, Laforet P, Blancho S, Marchand-Pauvert V, Bede P, Hogrel JY, Pradat PF. The motor unit number index (MUNIX) profile of patients with adult spinal muscular atrophy. Clin Neurophysiol. 2018;129:2333&#x2013;2340. doi: 10.1016/j.clinph.2018.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2018.08.025</ArticleId><ArticleId IdType="pubmed">30248623</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Hi Shing S, Chipika RH, Finegan E, Murray D, Hardiman O, Bede P. Post-polio syndrome: more than just a lower motor neuron disease. Front Neurol. 2019;10:773. doi: 10.3389/fneur.2019.00773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00773</ArticleId><ArticleId IdType="pmc">PMC6646725</ArticleId><ArticleId IdType="pubmed">31379723</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Walsh R, Fagan AJ, Hardiman O. "Sand-watch" spinal cord: a case of inferior cervical spinal cord atrophy. J Neurol. 2014;261(1):235&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24281771</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y, Plowman EK, Green JR, Barnett C, Bede P. Clinical measures of bulbar dysfunction in ALS. Front Neurol. 2019;10:106. doi: 10.3389/fneur.2019.00106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00106</ArticleId><ArticleId IdType="pmc">PMC6389633</ArticleId><ArticleId IdType="pubmed">30837936</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy. Arch Neurol. 2012;69:436&#x2013;440. doi: 10.1001/archneurol.2011.2308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.2308</ArticleId><ArticleId IdType="pubmed">22158719</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischbeck KH. Developing treatment for spinal and bulbar muscular atrophy. Prog Neurobiol. 2012;99:257&#x2013;261. doi: 10.1016/j.pneurobio.2012.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2012.05.012</ArticleId><ArticleId IdType="pmc">PMC3460036</ArticleId><ArticleId IdType="pubmed">22668795</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi A, Pennuto M. New routes to therapy for spinal and bulbar muscular atrophy. J Molecular Neurosci. 2013;50:514&#x2013;523. doi: 10.1007/s12031-013-9978-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-013-9978-7</ArticleId><ArticleId IdType="pubmed">23420040</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H, Adachi H, Katsuno M, Suzuki K, Atsuta N, Watanabe H, Tanaka F, Doyu M, Sobue G. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Ann Neurol. 2006;59:520&#x2013;526. doi: 10.1002/ana.20735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20735</ArticleId><ArticleId IdType="pubmed">16358333</ArticleId></ArticleIdList></Reference><Reference><Citation>Preisler N, Andersen G, Thogersen F, Crone C, Jeppesen TD, Wibrand F, Vissing J. Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease) Neurology. 2009;72:317&#x2013;323. doi: 10.1212/01.wnl.0000341274.61236.02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000341274.61236.02</ArticleId><ArticleId IdType="pubmed">19171827</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, D'Ascenzo C, Peterle E, Ermani M, Bello L, Melacini P, Morandi L, Mazzini L, Silani V, Raimondi M, Mandrioli J, Romito S, Angelini C, Pegoraro E, Sorar&#xf9; G. Pilot trial of clenbuterol in spinal and bulbar muscular atrophy. Neurology. 2013;80:2095&#x2013;2098. doi: 10.1212/WNL.0b013e318295d766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318295d766</ArticleId><ArticleId IdType="pubmed">23645595</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Miller R, Swan T, Glass DJ, El Mouelhi M, Fornaro M, Petricoul O, Vostiar I, Roubenoff R, Meriggioli MN, Kokkinis A, Guber RD, Budron MS, Vissing J, Sorar&#xf9; G, Mozaffar T, Ludolph A, Kissel JT, Fischbeck KH. Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. Lancet Neurol. 2018;17:1043&#x2013;1052. doi: 10.1016/S1474-4422(18)30320-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30320-X</ArticleId><ArticleId IdType="pmc">PMC6415539</ArticleId><ArticleId IdType="pubmed">30337273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume A, Katsuno M, Suzuki K, Banno H, Suga N, Mano T, Araki A, Hijikata Y, Grunseich C, Kokkinis A, Hirakawa A, Watanabe H, Yamamoto M, Fischbeck KH, Sobue G. A functional scale for spinal and bulbar muscular atrophy: cross-sectional and longitudinal study. Neuromuscul Disord. 2015;25:554&#x2013;562. doi: 10.1016/j.nmd.2015.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2015.03.008</ArticleId><ArticleId IdType="pmc">PMC5608513</ArticleId><ArticleId IdType="pubmed">25913211</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Finegan E. Revisiting the pathoanatomy of pseudobulbar affect: mechanisms beyond corticobulbar dysfunction. Amyotrophic Lateral Sclerosis Frontotemporal Degeneration. 2018;19:4&#x2013;6. doi: 10.1080/21678421.2017.1392578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1392578</ArticleId><ArticleId IdType="pubmed">29092641</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Chipika RH, Li Hi Shing S, Hardiman O, Bede P. Pathological crying and laughing in motor neuron disease: pathobiology, screening, intervention. Front Neurol. 2019;10:260. doi: 10.3389/fneur.2019.00260.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00260</ArticleId><ArticleId IdType="pmc">PMC6438102</ArticleId><ArticleId IdType="pubmed">30949121</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Heverin M, Bede P, Elamin M, Hardiman O. Fecundity in ALS. Amyotrophic Lateral Sclerosis Frontotemporal Degeneration. 2014;15:204&#x2013;206. doi: 10.3109/21678421.2013.865237.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.865237</ArticleId><ArticleId IdType="pubmed">24479554</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver D, Maguire S, Hardiman O, Bede P. Neurodegenerative Disorders. London: Springer; 2016. Palliative care and end of life care; pp. 305&#x2013;319.</Citation></Reference><Reference><Citation>Bede P, O'Brannag&#xe1;in D, Lorenzl S, Oliver D, Hardiman O. Neurodegenerative Disorders. London: Springer; 2011. Symptomatic management and palliative care in neurodegenerative disease; pp. 263&#x2013;289.</Citation></Reference><Reference><Citation>Murty MS, Sharma UK, Pandey VB, Kankare SB. Serum cystatin C as a marker of renal function in detection of early acute kidney injury. Indian J Nephrol. 2013;23:180&#x2013;183. doi: 10.4103/0971-4065.111840.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-4065.111840</ArticleId><ArticleId IdType="pmc">PMC3692142</ArticleId><ArticleId IdType="pubmed">23814415</ArticleId></ArticleIdList></Reference><Reference><Citation>HauteAutorit&#xe9;DeSant&#xe9; (2013) Niveau de preuve et gradation des recommandations de bonne pratique. http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-06/etat_des_lieux_niveau_preuve_gradation.pdf.</Citation></Reference><Reference><Citation>HauteAutorit&#xe9;DeSant&#xe9; (2017) Amyotrophie bulbo-spinale li&#xe9;e &#xe0; l&#x2019;X ou maladie de Kennedy. https://www.has-sante.fr/jcms/c_2776017/fr/amyotrophie-bulbo-spinale-liee-a-l-x-ou-maladie-de-kennedy.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>